Furthermore, cetuximab, an anti-EGFR monoclonal antibody, was found to reinforce oridonin-induced apoptosis by ER stress and mitochondrial pathway in laryngeal cancer 27-28. The gene discussed is EGFR; the disease is laryngeal carcinoma.